4D Molecular Therapeutics, Inc. Common Stock
FDMT Real Time Price USDRecent trades of FDMT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by FDMT's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Dec. 12, 2023
-
Patent Title: Adeno-associated variants, formulations and methods for pulmonary delivery Nov. 07, 2023
-
Patent Title: Adeno-associated virus variant capsids and use for inhibiting angiogenesis Sep. 26, 2023
-
Patent Title: Treatments for retinal disease Sep. 26, 2023
-
Patent Title: Treatments for retinal disease Feb. 14, 2023
-
Patent Title: Codon optimized rep1 genes and uses thereof Dec. 13, 2022
-
Patent Title: Adeno-associated variants, formulations and methods for pulmonary delivery Nov. 15, 2022
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Aug. 23, 2022
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Jun. 21, 2022
-
Patent Title: Codon optimized rep1 genes and uses thereof Jun. 14, 2022
-
Patent Title: Codon optimized rpgrorf15 genes and uses thereof May. 31, 2022
-
Patent Title: Codon optimized gla genes and uses thereof Dec. 14, 2021
-
Patent Title: Method of using adeno-associated virus with variant capsid Nov. 23, 2021
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Nov. 09, 2021
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Sep. 14, 2021
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of FDMT in WallStreetBets Daily Discussion
Recent insights relating to FDMT
Recent picks made for FDMT stock on CNBC
ETFs with the largest estimated holdings in FDMT
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view FDMT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.